A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer metabolism by controlling the powerful mTOR growth pathway, tying survival and energy use together. This insight explains why MCL1-targeting drugs can be effective—but also why they sometimes damage the heart. Researchers have now identified a way to reduce that risk, potentially unlocking safer cancer therapies.
source https://www.sciencedaily.com/releases/2026/01/260104202819.htm
Two of the lightest-ever Windows laptops launch soon — here's how Lenovo
and ASUS with Snapdragon and Intel CPUs compare
-
Lenovo's Yoga Slim 7i Ultra Aura Edition wants to compete with the glorious
ASUS Zenbook A14, also refreshed for 2026. I put together this comparison
to he...
3 hours ago
No comments:
Post a Comment